Monoclonal antibodies reactive with activated and oncogenic...

Details Monoclonal antibodies reactive with activated and oncogenic... Monoclonal antibodies reactive with activated and oncogenic...

C - Chemistry, Metallurgy

07

K

195/1.112

C07K 14/82 (2006.01) C07K 16/32 (2006.01) C12N 5/06 (2006.01)

Patent

CA 1294902

TITLE MONOCLONAL ANTIBODIES REACTIVE WITH ACTIVATED AND ONCOGENIC RAS P21 PROTEINS ABSTRACT OF THE DISCLOSURE Monoclonal antibodies reactive with oncogenic and activated ras p21 proteins containing glutamic acid or arginine at position 12 and unreactive with normal ras p21 proteins containing glycine at position 12. The antibodies are secreted by hybridomas obtained by immunizing mice with synthetic dodecapeptides corresponding in amino acid sequence to positions 5-16 of normal ras p21 proteins, except having glutamic acid or arginine in place of glycine at position 12. The antibodies and immunoreactive fragments thereof are useful for diagnosis, staging and classification of malignant and premalignant lesions.

562099

Affiliated with

Also associated with

Rating

Monoclonal antibodies reactive with activated and oncogenic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monoclonal antibodies reactive with activated and oncogenic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies reactive with activated and oncogenic... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1183116